Breast Cancers Today Videos

Advertisement
Hatem Soliman, MDHER2 Breast Cancer | April 29, 2025
Dr. Soliman explores dendritic cell vaccines to boost immunity and cut chemo toxicity in early HER2-positive breast cancer.
View More
Hatem Soliman, MDHER2 Breast Cancer | April 29, 2025
Pilot study shows HER2-targeted dendritic cell vaccines may enhance immune response in early HER2-positive breast cancer.
Sara Nunnery, MD, MSCIHER2 Breast Cancer | April 28, 2025
Dr. Nunnery weighs IV Enhertu vs oral chemo, highlighting how patient goals and QoL shape treatment decisions.
Sara Nunnery, MD, MSCIHER2 Breast Cancer | April 22, 2025
Dr Nunnery discusses HER2-low and ultralow testing and Enhertu’s role after DESTINY-Breast06 in metastatic breast cancer.
Dr. Sadie Dobrozsi, EvolentGenetics & Breast Cancer | March 26, 2025
Dr. Sadie Dobrozsi spoke on the importance of genetic testing in breast cancer to better understand the disease.
Leah Pyter, PhDBreast Cancer News | March 26, 2025
Dr. Leah Pyter details a study which found that chemotherapy induces microbiome disruption and inflammation in BC patients.
Dr. Mik RinneHR Breast Cancer | July 19, 2024
Dr. Mik Rinne discusses a study on the efficacy of the CDK2 inhibitor BLU-222 in patients with HR+/HER2- breast cancer.
Carlos Doti, MDBreast Cancer News | March 26, 2025
Carlos Doti, MD, of AstraZeneca, discusses the impact of LYNPARZA over the last decade.
Nera Lopetegui-Lia, MDHER2 Breast Cancer | March 31, 2025
Dr. Lopetegui-Lia reacts to Dr. Gatti-Mays' breast cancer panel discussion from Advancements in Oncology.
Dr. Margaret Gatti-MaysAdvancements in Oncology | June 13, 2024
Dr. Margaret Gatti-Mays explains what makes The Oncology Brothers' content so important for community oncologists.
Dr. Margaret Gatti-MaysBreast Cancer News | March 26, 2025
Dr. Margaret Gatti-Mays explains how to address the most pressing questions in triple-negative breast cancer treatments.
Dr. Margaret Gatti-MaysTriple-Negative Breast Cancer | March 26, 2025
Dr. Gatti-Mays discusses how treatment for triple-negative breast cancer has evolved in recent years.
Dr. Margaret Gatti-MaysHER2 Breast Cancer | March 31, 2025
Dr. Margaret Gatti-Mays delves into the topic of HER2 tumor expression in breast cancer.
Dr. Eric VachonBreast Cancer News | March 26, 2025
A study examined the impact of relationship satisfaction and agreement between breast cancer survivors and their partners.
Dr. Margaret Gatti-MaysBreast Cancer News | March 26, 2025
Dr. Gatti-Mays talks about the importance of tailoring treatments to individual patients with breast cancer.
Dr. Barbara SmithBreast Cancer News | March 26, 2025
Barbara Smith, MD, PhD, discusses the Lumicell Direct Visualization System and how it can enhance breast cancer detection.
Dr. Timothy YapHER2 Breast Cancer | March 26, 2025
Dr. Timothy Yap discusses the PETRA trial, which showed the efficacy of saruparib in treating HER2-negative breast cancer.
Dr. Samilia Obeng-GyasiBreast Cancer News | March 26, 2025
Dr. Samilia Obeng-Gyasi discusses how social factors can impact outcomes in breast cancer patients.
Ashley GainesHR Breast Cancer | March 26, 2025
The FDA recently approved a new combination therapy for the treatment of HR-positive, HER2-negative breast cancer.
Oncology BrothersHR Breast Cancer | March 26, 2025
The Oncology Brothers talk with Paolo Tarantino, MD, about the TROPiCS-02 study presented at SABCS.
Advertisement
Advertisement
Latest News

April 30, 2025